ANI Pharmaceuticals, Inc.

Overview

ANI Pharmaceuticals, Inc. is a U.S.-focused biopharmaceutical company dedicated to developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceuticals. Founded in the 1930s, the organization has evolved significantly, incorporating in 2001 and entering the NASDAQ exchange through a pivotal reverse merger in 2013. Its mission of "Serving Patients, Improving Lives" reflects a strong commitment to addressing unmet medical needs through innovative therapeutics and consistent, reliable supply.

The company operates across Rare Disease, Generics, and Established Brands business segments. The Rare Disease segment develops novel products for areas such as ophthalmology and neurology, while the Generics division uses extensive R&D expertise to expand a portfolio of generic medications. The Established Brands group includes key therapies like Purified Cortrophin Gel, and the company also provides contract development and manufacturing services to the wider pharmaceutical sector, driving revenue and expanding operational capacity.

Basic Information

Contact Details

• Phone: +1 218-634-3500
• Website: anipharmaceuticals.com
• LinkedIn: linkedin.com/company/ani-pharmaceuticals-inc-

Key Focus Areas & Initiatives

• hormone manufacturing & packaging
• solid dose manufacturing & packaging
• contract packaging
• liquid dose manufacturing & packaging
• controlled substances
• rare disease
• generics
• established brands
• contract manufacturing
• oncolytics
• cortrophin
• biotechnology: pharmaceutical preparations
• health care
• pharmaceutical manufacturing
• product portfolio management
• rheumatology products
• pulmonology drugs
• u.s. pharmaceutical manufacturing
• specialty pharmaceuticals
• acquisition strategy
• medical devices
• fda regulatory approvals
• u.s. contract manufacturing
• drug efficacy testing
• drug formulation expertise
• rheumatology drugs
• manufacturing
• pharmaceutical supply chain
• pulmonology products
• manufacturing capabilities
• nephrology drug manufacturing
• ophthalmology products
• patient-focused therapeutics
• innovative drugs
• drug safety
• pharmaceuticals
• u.s. pharma market focus
• clinical development
• patient outcomes
• services
• biotech collaborations
• biopharma manufacturing
• patient-centric approach
• innovative pharmaceutical products
• drug development
• regulatory compliance
• patient care solutions
• pharmaceutical product launch
• market access
• pharmaceutical quality control
• pharmaceutical partnerships
• clinical trials management
• regulatory submissions
• generic drug manufacturing
• pharmaceutical innovation pipeline
• drug pipeline
• rare disease therapeutics
• specialty pharma
• drug development for rare diseases
• drug approval process
• nephrology drugs
• neurology drug pipeline
• acquisitions
• biopharmaceutical
• specialty pharmaceutical manufacturing
• biotechnology
• sustainable growth strategies
• regulatory strength
• u.s. pharma industry
• manufacturing excellence
• fda regulatory submissions
• drug r&d
• biotech drug development
• healthcare equipment & supplies
• neurology drugs
• clinical trial support
• product commercialization
• regulatory expertise
• u.s. pharma manufacturing hub
• u.s. manufacturing facilities
• specialty pharma growth
• acquisition and integration
• contract development and manufacturing
• rare disease drug pipeline
• pharmaceutical quality
• neurology medications
• bioscience manufacturing
• drug licensing
• b2b
• regulatory inspections
• pharmaceutical supply chain management
• rheumatology drug development
• nephrology treatments
• pharmaceutical quality standards
• sustainable growth
• product diversification
• high-quality prescription drugs
• pharmaceutical and medicine manufacturing
• product innovation
• rare disease market
• pulmonology drug development
• nephrology products
• market expansion
• pharmaceutical r&d
• neurology products
• pharmaceutical quality assurance
• pharmaceutical innovation
• product portfolio
• supply chain management
• generic pharmaceuticals
• u.s. healthcare market
• patient care
• u.s.-based manufacturing
• rare disease therapies
• high-quality therapeutics
• fda approvals
• market access solutions
• regulatory affairs
• product development
• pulmonology therapies
• pharmaceutical compliance
• ophthalmic drug manufacturing
• regulatory compliance in pharma
• drug development pipeline
• ophthalmology therapeutics
• u.s. healthcare providers
• fda-approved facilities
• ophthalmology drugs
• pharmaceutical supply chain resilience
• biopharmaceutical development
• product lifecycle management
• pharmaceutical logistics
• market access strategies
• drug safety monitoring
• clinical research
• drug manufacturing
• u.s. pharmaceutical supply chain
• clinical trials
• drug formulation
• fda approval process for rare diseases
• bio-pharmaceutical
• branded pharmaceuticals
• fda approval
• cortrophin gel
• rare diseases
• high unmet medical need
• research and development
• commercial operations
• north american manufacturing
• generic therapies
• pharmaceutical marketing
• licensed products
• prescription medication
• quality control
• active pharmaceutical ingredients
• partnerships
• market penetration
• sales growth
• drug commercialization
• pharmaceutical distribution
• therapeutic areas
• drug formulations
• financial performance
• investor relations
• corporate governance
• executive leadership
• pharmaceutical sales
• marketing strategy
• operational excellence
• generics business
• product pipeline
• investor communications
• regulatory approvals
• healthcare solutions
• medical information
• product launches
• safety information
• employment opportunities
• healthcare
• mechanical or industrial engineering
• health, wellness & fitness
• medical
• hospital & health care
• logistics & supply chain
• research & development
• marketing & advertising

Technologies Used

• AI
• Outlook
• Remote
• Salesforce

Affiliated Organizations & Regional Branches

• Novitium Pharma LLC
• Pandel®